Outcome in patients with adrenal incidentaloma selected for surgery: An analysis of 88 cases investigated in a single clinical center

European Journal of Endocrinology

Volumn 143, Issue 1, 2000, Pages 111-117

  Luton, Jean Pierre ^a   Martinez, Monique ^a   Coste, Joël ^a   Bertherat, Jérôme ^a  

^a Univ Rene Descartes Paris V ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL HYPERPLASIA; ADRENAL METASTASIS; ADULT; AGED; ARTICLE; CUSHING DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033910324     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1430111     Document Type: Article

References (52)

1. Caplan RH, Strutt PJ & Wickus GG. Subclinical hormone secretion by incidentally discovered adrenal masses. Archives of Surgery 1994 129 291-296.
2. Prinz RA, Brooks MH, Churchill R, Graner JL, Lawrence AN, Paloyan E et al. Incidental asymptomatic adrenal masses detected by computed tomographic scanning. Journal of the American Medical Association 1982 248 701-704.
3. Herrera MF, Grant CS, Van Heerden JA, Sheedy PF & Ilstrup DM. Incidentally discovered adrenal tumors: an institutional perspective. Surgery 1991 110 1014-1021.
4. Kley HK, Wagner H, Jaresch S, Jungbluth R & Schlaghecke R. Endokrin inaktive nebennierentumoren. In Moderne Diagnostik und therapeutische Strategien bei Nebennierenerkrankungen, pp 189-197. Eds B Allolio & HM Schulte. Stuttgart, New York: Schattauer. 1990.
5. Vidal-Trecan G, Laudat MH, Thonopoulos P, Luton JP & Bricaire H. Urinary free corticoids: an evaluation of their usefulness in the diagnosis of Cushing's syndrome. Acta Endocrinologica 1983 15 110-115.
6. Barrou Z, Guiban D, Maroufi A, Fournier C, Dugué MA, Luton JP et al. Overnight dexamethasone suppression test: comparison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome. European Journal of Endocrinology 1996 134 93-96.
7. Revol A, Comoy E, Forzy G, Garnier JP, Gerhardt MF, Hirth C et al. Méthodes recommandées pour le dosage des catécholamines et de leur métabolites dans l'urine. Annales de Biologie Clinique 1994 52 625-637.
8. Terzolo MG, Osella G, Ali A, Reimondo G, Borretta G, Magro GP et al. Adrenal incidentaloma, a live year experience. Minerva Endocrinologica 1995 20 69-78.
9. Aso Y & Homma Y. A survey of incidental adrenal tumors in Japan. Journal Urology 1992 147 1478-1481.
10. Cook DM & Loriaux CL. The incidental adrenal mass. American Journal of Medicine 1996 101 88-95.
11. Gajraj H & Young AE. Adrenal incidentaloma. British Journal of Surgery 1993 80 422-426.
12. Krane NK. Clinically unsuspected pheochromocytomas. Experience of Henry Ford Hospital and review of the literature. Archives of Internal Medicine 1986 146 54-57.
13. Kloos RT, Gross MD, Francis IR, Korobkin M & Shapiro B. Incidentally discovered adrena masses. Journal of Clinical Endocrinology and Metabolism 1995 16 460-484.
14. Krestin GP, Steinbrich W & Friedmann G. Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies. Radiology 1989 171 675-680.
15. Katz R & Shirkhoda A. Diagnostic approach to incidental adrenal nodules in the cancer patient. Results of clinical, radiologic, and fine-needle aspiration study. Cancer 1985 55 1995-2000.
16. Krestin G, Friedmann G, Fischbach R, Neufang KFR & Allolio B. Evaluation of adrenal masses in oncologic patients: dynamic contrast-enhanced MR vs CT. Journal of Computer Assisted Tomography 1991 15 104-110.
17. Candel A, Gattuso P, Reyes CV, Prinz RA & Castelli MJ. Fine-needle aspiration biopsy of adrenal masses in patients with extraadrenal malignancy. Surgery 1993 114 1132-1136.
18. Dominguez-Gadea L, Dieu L, Bas C & Crespo A. Differential diagnosis of solid adrenal masses using adrenocortical scintigraphy. Clinical Radiology 1944 49 796-799.
19. Kohayashi S, Seki T, Nonomura K, Gotoh T, Togashi M & Koyanagi T. Clinical experience of incidentally discovered adrenal tumor with particular reference to cortical function. Journal of Urology 1993 150 8-12.
20. Angeli A, Osella G & Terzolo M. Adrenal incidentaloma: an overview of clinical and epidemiological data from the national Italian study group. Hormone Research 1997 47 279-283.
21. Copeland PM. The incidentally discovered adrenal mass. Annals of Internal Medicine 1983 98 940-945.
22. Gold PW, Loriaux DL & Roy A. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. New England Journal of Medicine 1986 314 1329-1335.
23. Noritake M, Moritomo K, Kosano H, Nemoto Y, Kugai N, Takao M et al. A case of asymptomatic cortisol producing adrenal adenoma. Endocrinology Japonica 1992 39 19-24.
24. Cugini P, Campisi C, Castagna G, Batistti P, Di Palma L, Coppola A et al. Pre-Cushing's syndrome: a case report. Endocrinologia Japonica 1992 39 407-411.
25. Suzuki H, Shibata H, Maruyama T, Ishimura Y & Saruta T. Significance of steroidogenic enzymes in the pathogenesis of hyperfunctioning and non-hyperfunctioning adrenal tumor. Steroids 1995 60 42-47.
26. Ambrosi B, Re T, Passini E, Peverelli S, Sartorio A & Colombo P. Aspetti clinici e preclinici della sindrome di Cushing surrenalica. Minerva Endocrinologica 1995 20 39-47.
27. Beyer HS & Doe RP. Cortisol secretion by an incidentally discovered non functional adrenal adenoma. Journal of Clinical Endocrinology and Metabolism 1985 62 1317-1321.
28. Reicke M, Nieke J, Krestin GP, Saeger X, Allolio B & Winkelmann W. Preclinical Cushing's syndrome in adrenal incidentalomas: comparaison with adrenal Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 1992 75 826-832.
29. Tojo K, Abe A, Sato S, Hamaguchi A, Kato N, Furuta N et al. The incidentally discovered asymptomatic cortisol-producing adrenal adenoma pre-Cushing's syndrome. Jikeikai Medical Journal 1995 42 93-101.
30. Tsuboi Y, Ishikawa SE, Fujisawa G, Okada K & Saito T. Possible pre-Cushing's syndrome due to an adrenal adenoma incidentally discovered. Endocrine Journal 1995 42 509-516.
31. Rosen HN & Swartz SL. Subtle glucocorticoid excess in patients with adrenal incidentaloma. American Journal of Medicine 1992 92 213-216.
32. Delemer B, Gibold C, Caron J, Liehn JC & Delisle MJ. Place de la scintigraphic corticosurrénalienne dans l'exploration des incidentalomes. Annals of Endocrinology 1992 53 147-152.
33. Francis IR, Gross MD, Shapiro B, Korobkin M & Quint LE. Integrated imaging of adrenal disease. Radiology 1992 184 1-13.
34. Gross MD, Shapiro B, Francis IR, Glaze MG, Bree RL, Arcomano RA et al. Scintigraphic evaluation of clinically silent adrenal masses. Journal of Nuclear Medicine 1994 35 1145-1151.
35. Flecchia D, Mazza E, Carlini M, Blatto A, Olivieri F, Serra G et al. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour. Clinical Endocrinology 1995 42 129-134.
36. Osella G, Terzolo M, Borreta G, Magro G, Ali A, Olivieri F et al. Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). Journal of Clinical Endocrinology and Metabolism 1994 79 1532-1539.
37. Young J & Schaison G. Que savons-nous de la DHEA? Revue Française d'Endocrinologie Clinique. Nutrition et Metabolisme 1996 37 390-398.
38. Bathia V, Mishra SK, Gupta RK & Gandhi S. Adrenal tumor complicating untreated 21-hydroxylase deficiency in a 5-year-old boy. Archives of Pediatrics and Adolescent Medicine 1994 148 994-995.
39. Jaresch S, Kornely E, Kley HK & Schlaghecke R. Adrenal incidentaloma in patients with homozygous or heterozygous congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 1992 74 685-689.
40. Mantero F, Masini AM, Opocher G, Giovagnetti M & Arnaldi G. Adrenal incidentaloma: an overview of hormonal data from the national Italian study group. Hormone Research 1997 47 284-289.
41. Leroy-Wills A, Bittoun J, Luton JP, Louvel A, Lefevre JE, Bonnin A et al. In vivo MR spectroscopic imaging of the adrenal glands: distinction between adenomas and carcinomas larger than 15 mm based on lipid content. American Journal of Roentgenology 1989 153 771-773.
42. Cerfolio RJ, Vaughan ED, Brennan TG, & Hiverla ER. Accuracy of computed tomography in predicting adrenal tumor sine. Surgery 1993 176 307-309.
43. Berland LL, Koslin DB, Kenney PJ, Stanley RJ & Lee JY. Differentiation between small benign and malignant adrenal masses with dynamic increment CT. American Journal of Roentgenology 1988 151 95-101.
44. Lee MJ, Hahn PF, Papanicolaou N, Agglin TK, Saisi S, Mueller PR et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991 179 415-418.
45. Miyake H, Maeda H, Tashiro M, Susuki K, Nagatomo H, Aikawa H et al. CT of adrenal tumor: frequency and clinical significance of low-attenuation lesions. American Journal of Roentgenology 1989 152 1005-1007.
46. Leroy-Willis A, Roucayrol JC, Luton JP, Courtieu J, Niensenbaum N & Louvel A. In vitro adrenal cortex lesion characterization by NMR spectroscopy. Magnetic Resonance Imaging 1987 5 339-544.
47. Hussain S, Belldegrun A, Seltzer SE, Richie JP, Gittes RF & Abrams HL. Differentiation of malignant from benign adrenal masses: predictive indices on computed tomography. American Journal of Roentgenology 1985 144 61-65.
48. Dunnick NR, Heaston D, Halvorsen R, Moore AV & Korobkin M. CT appearance of adrenal cortical carcinoma. Journal of Computer Assisted Tomography 1982 6 978-982.
49. Lee MJ, Mayo-Smith WW, Hahn PE, Goldberg MA, Boland GW, Saini S et al. State-of-the-art MR imaging of the adrenal gland. Scientific Exhibit 1994 14 1015-1032.
50. Tsushima T, Ishizaka H & Matsumoto M. Adrenal masses: differentiation with chemical shift, fast low-angle shot MR imaging. Radiology 1995 186 705-709.
51. Mitchell DJ, Crovello M, Matteucci T, Petersen RO & Mittinen MM. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 1992 185 545-551.
52. Boland GW, Goldberg MA, Lee MJ, Mayo-Smith WW, Dixon J, Mi-Nicholas MM et al. Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-F-18-fluoro-2-deoxy-D-glucose. Radiology 1995 194 131-134.